Diligence memo · auto-generated · as of July 3, 2026
Koronis Antiviral Partners II, L.P.
Koronis Antiviral Partners II, L.P. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Koronis Antiviral Partners II, L.P. operates in Other, based in SEATTLE.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Koronis Antiviral Partners II, L.P. has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.0M on 2009-09-22.
Most recent recorded round closed around 2009-09-22.
Valuation (modeled)modeled
Provath models Koronis Antiviral Partners II, L.P. at approximately $19M (range $940K–$152M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.52× the median modeled value of Seed Other companies in 2007–2009 (281 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 16.8 yr ago; this sector typically re-raises about every 11 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 38% of Other peers (25015 compared).
Modeled value ranks above 52% of those peers.
Closest niche peers: Secret Ridge Estates, L.L.C., Pluribus Entertainment LLC, EPI Holdings, Pbsj Corp /Fl/, Haney Transportation & Logistics, LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.